Atorvastatin Calcium Tablet
Product Images NDC 71335-9646

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 71335-9646). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atorvastatin-calcium (Atorvastatin Calcium)

Atorvastatin-calcium (Atorvastatin Calcium)
Chemical structure of atorvastatin calcium, shown as the molecular arrangement with calcium ions and hydrate water molecules indicated.*
FDA Label Image

Figure-1-atorvastatin-calcium (Figure 1 Atorvastatin Calcium)

Figure-1-atorvastatin-calcium (Figure 1 Atorvastatin Calcium)
A line graph depicting cumulative incidence (%) of disease death over 3.5 years in the ASCOT-LLA study. Two lines compare Atorvastatin and Placebo groups, showing lower disease death incidence with Atorvastatin. The hazard ratio and significance (HR=0.64, p=0.0005) are noted on the graph.*
FDA Label Image

Figure-2-atorvastatin-calcium (Figure 2 Atorvastatin Calcium)

Figure-2-atorvastatin-calcium (Figure 2 Atorvastatin Calcium)
A cumulative hazard line graph showing the comparison of placebo versus atorvastatin over a 5-year period. The x-axis represents time to the first primary endpoint through four years of follow-up in years, and the y-axis shows cumulative hazard percentage. The graph includes hazard ratio (HR) 0.63 with confidence interval (0.48-0.83) and a p-value of 0.001, illustrating lower cumulative hazard with atorvastatin compared to placebo.*
FDA Label Image

Figure-3-atorvastatin-calcium (Figure 3 Atorvastatin Calcium)

Figure-3-atorvastatin-calcium (Figure 3 Atorvastatin Calcium)
A line graph comparing the percentages of subjects experiencing a major cardiovascular event over a 5-year period for Atorvastatin 10 mg and 80 mg dosages. The x-axis represents time to first major cardiovascular endpoint in years, and the y-axis shows the percentage of subjects experiencing the event. The graph includes a hazard ratio with confidence interval and a p-value indicating statistical significance.*
FDA Label Image

Label (Lbl713359646)

Label (Lbl713359646)
Label of Atorvastatin Calcium 80 mg tablet by Bryant Ranch Prepack. The label includes a comparison to Lipitor 80 mg tablets by Umedica Laboratories Pvt. Ltd., the NDC 71335-96461, a barcode, and storage instructions to keep the container tightly closed and store at room temperature (20°-25°C or 68°-77°F). The label mentions the tablet is white and oval-shaped with imprint 'ATO;80'.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.